Political and economic uncertainty hangs over the industry, while major bets on metabolic and immune disease drug research are set to play out.
New research from University of Iowa dispels the belief that pharmaceutical mergers lead to higher drug prices, showing a decrease in prices for generic drugs.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback